Safe and efficient systems capable of specifically targeting brain tumour cells represent a promising approach for the treatment
glioblastoma multiforme.
Neuropilin-1 (NRP-1) is over-expressed in U87
glioma cells. In the current study, the tumour specific
peptide RGERPPR, which binds specifically to NRP-1, was used as a targeting
ligand in a gene delivery strategy for
glioblastoma. The
RGERPPR peptide was coupled to branched
polyethylenimine (PEI, 25kDa) using heterobifunctional Mal-PEG-NHS, resulting in a novel gene delivery
polymer.
Polymer/plasmid
DNA (pDNA) complexes were formed and their sizes and zeta potentials were measured. Compared with the unmodified
mPEG-PEI/pDNA complexes, the RGERPPR-
PEG-PEI/pDNA complex led to a significant enhancement in intracellular gene uptake and tumour spheroid penetration. Furthermore, the RGERPPR-
PEG-PEI/pDNA complex facilitated enhanced transfection efficiency levels, as well as a reduction in cytotoxicity when tested in U87
glioma cells in vitro. Most significantly of all, when complexes formed with pDsRED-N1 were injected into the tail vein of intracranial U87 tumour-bearing nude mice, the RGERPPR-
PEG-PEI complexes led to improved levels of red fluorescence
protein expression in the brain tissue. Taken together, the results show that RGERPPR-
PEG-PEI could be used as a safe and efficient gene delivery vehicle with potential applications in
glioblastoma gene delivery.